According to Amylyx Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -HK$1.21 B. In 2023 the company made an earning of HK$0.30 B an increase over its 2022 earnings that were of -HK$1.57 B.The earnings displayed on this page is the company's Pretax Income.